Evidence map›Paper›PMID 34695783›Full record

ArticleThe American journal of tropical medicine and hygiene2021

Proxy Responses for Mass Drug Administration Coverage Surveys: The Trends and Biases When Others are Allowed to Respond.

Rini Jose, Roland Bougma, Franck Drabo, Edridah Muheki Tukahebwa, Square Mkwanda, Katherine Gass

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Rini JoseDepartment of Epidemiology and Biostatistics, Dornsife School of Public Health, Drexel University, Philadelphia, Pennsylvania.
Roland BougmaDirection de la Protection de la Santé de la Population, Ministère de la Santé, Ouagadougou, Burkina Faso.
Franck DraboDirection de la Protection de la Santé de la Population, Ministère de la Santé, Ouagadougou, Burkina Faso.
Edridah Muheki TukahebwaVector Control Division, Ministry of Health, Kampala, Uganda.
Square MkwandaLymphatic Filariasis Control Program, Ministry of Health and Population, Lilongwe, Malawi.
Katherine GassNeglected Tropical Disease Support Center, Task Force for Global Health, Decatur, Georgia.
Ministère De La Santé · BFDrexel University · USMinistry of Health · UGMinistry of Health · MWThe Task Force for Global Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coverage surveys for mass drug administration (MDA) rely on respondent recall and often permit proxy responses, whereby another household member is allowed to respond on behalf of an absent individual. In this secondary analysis of coverage surveys in Malawi, Burkina Faso, and Uganda, we explore the characteristics of individuals who require proxy responses and quantify the association between proxy responses and reported drug coverage. The adjusted logistic regression model found that men 11-39 years and women 11-18 years who were eligible for MDA had greater odds of requiring a proxy response compared with ineligible men and women in the same age groups. A hierarchical multivariable analysis found that proxy responses had 1.70 times the odds of reporting ingestion of MDA drugs compared with first-person responses, controlling for age and sex (95% CI: 1.17, 2.46). This finding is surprising, given that individuals absent during a coverage survey may also have been absent during the MDA, and suggests that proxy responses may be leading to an inflation of survey estimates of drug coverage. This study highlights the possibility for recall bias in proxy responses to MDA coverage; however, excluding absent individuals from coverage surveys would introduce a new bias. Further research is necessary to determine the best method for obtaining information on drug coverage when individuals are absent.

Indexed as

ProxyAdolescentAdultAlbendazoleAnthelminticsAnti-Bacterial AgentsAntiparasitic AgentsAzithromycinBurkina FasoChildDemographyFemaleHumansIvermectinLogistic ModelsMalawiAlbendazoleAnthelminticsAnti-Bacterial AgentsAntiparasitic AgentsAzithromycinIvermectinPraziquantel

Identifiers

PMID34695783
PMCPMC8733507
OpenAlexW3208758725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.